Health Care Sciences
|Human Movement Lab||Gerry Conti||1336|
|Human Performance Lab||Moh Malek||1228|
|Instructional Technology Lab||2231|
Both motor (e.g., walking, strength, balance) and cognitive (e.g. thinking, memory, attention) factors interact to influence rehabilitation outcomes. The overarching goal of our lab is to develop novel rehabilitation strategies to target motor and cognitive decline in individuals with neurodegenerative diseases, including multiple sclerosis and Huntington's disease.
Neuromuscular Regenerative Rehabilitation Research Group (NR3G)
Improving or optimizing muscle function in all individuals. Researchers are engaged in several studies aimed at gaining a better understanding of why individuals with certain neuromuscular diseases show greater levels of exercise-induced muscle injury. With the knowledge gained from these studies, they hope to develop novel rehabilitative, pharmacological, gene- and cell-based therapies that could improve resistance to muscle injury in individuals with neuromuscular diseases as well as in healthy individuals.
|Joseph A. Roche||4440|
|Neurotechnology Lab||Sujay Galen and Victoria Pardo||1210|
Developing and characterizing animal models that simulate health consequences of air pollluntants such as ozone and cigarette smoke in normal populations and in individuals whose lungs are compromised by a co-pollutant, infection or prior inflammation.
Investigating genetic and epigenetic effectives of extracellular inducers, including ROS and cytokines, on the development and progression of human lung and other cancers caused by exposure to varied agents, including mineral dust and carcinogenic metals
Seeking to further understanding of the neuroanatomical sites and neuropharmacological mechanisms for the actions of drugs and other chemicals on behavior.
Studying cellular injury and cell death as well as factors governing drug and chemical-induced injuries, including drug metabolism and nutrition.
|Driving Simulator Lab||Randall Commissaris||1215|
Investigating the mechanism of action of novel CNS active molecules and advancing promising leads to preclinical studies.
|Aloke K. Dutta||4340|
Exploring the discovery and elucidation of anti-infective agents.
Examining translocation and modifications of annexin A1 in nuclei to explore its role in carcinogenesis and cell transformation.
Developing use-inspired nano-medical technologies aimed towards clinical translation using biocompatible delivery systems that have enhanced disease targeting with reduced toxicity burden to patients.
Working to identify specific genes that must be regulated by glucose to induce insulin secretion, to determine novel drug targets to rectify these defects, and to develop beta cells resistant to immune attack for use in transplantation of Type 1 diabetes
Explores methamphetamine neurotoxicity and the role of ubiquitin E3 ligases in neuronal damage.
|Pitts Lab||David Pitts||3430|
|Proteomics Lab||Zhengping Yi||0250|
|Qin Lab||Zhihui Qin||3341|
Studying molecular mechanisms underlying cell death caused by oxidative stress after photodynamic therapy, a cancer treatment modality.
Obtaining a molecular/atomic level characterization of the structure and function of biomolecules involved in cellular metal homeostasis pathways.
Developing of a better understanding of the basic biology of insulin signaling and the etiology of insulin resistance.